1. Introduction
===============

Bladder cancer (BCa) is one of the top ten common malignancies all over the world.^\[[@R1]\]^ In China, the incidence and mortality of BCa ranked first among all genitourinary neoplasms during recent years, which accounted for 80,500 new cases and 32,900 deaths annually.^\[[@R2]\]^ Epidemiologic studies have identified that both tobacco smoking and occupational exposures to industrial chemicals contributed to the risk of BCa, which may account for 50% and 6% of BCa cases, respectively.^\[[@R3]\]^ Besides smoking and occupational exposures, studies have also reported familial aggregated BCa^\[[@R4],[@R5]\]^ and an estimated familial risk of 30% was revealed,^\[[@R6]\]^ indicating the importance of genetic factors in the development of BCa. Although family history may reflect inherited risk, this can be affected by the size of family and lack of information. In addition, family history may not be informative in evaluating the inherited risk for most people due to the low incidence of family aggregated BCa.^\[[@R4]--[@R7]\]^

Recently, genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNPs) associated with the inherited risk of BCa.^\[[@R8]--[@R11]\]^ These SNPs have a low to moderate effect on BCa risk, with OR ranging from 1.1 to 1.6. Genetic risk score (GRS) based on SNPs is considered as a useful and generally applicable tool to evaluate the inherited risk for each individual. For individuals who carry more than one risk alleles, GRS could calculate the cumulative effect of all genetic variants.^\[[@R12]\]^ In terms, the result of GRS value is one\'s relative risk to the general population, which makes it easy to implement for individual risk assessment.

In this study, we aimed to validate eight previously reported risk-associated SNPs of BCa in Chinese population and then evaluate whether GRS based on these SNPs could reflect the risk of BCa for each individual.

2. Methods
==========

2.1. Study cohort
-----------------

581 BCa patients were recruited from Huashan Hospital, Fudan University, Shanghai, China between 2010 and 2017. All cases were diagnosed as BCa based on pathologic diagnosis. The control group consisted of healthy subjects who had undergone routine physical examination either at Huashan Hospital or in local communities in Shanghai (n = 1561).

2.2. DNA sampling, SNP selection and genotyping
-----------------------------------------------

1.  A blood sample was obtained from each participant for DNA extraction at the time of recruitment. Genomic DNA was extracted from leucocytes of peripheral blood using QIAamp DNA Blood Mini Kit (QIAGEN, Germany) according to the standard protocol. Candidate SNPs were identified referring to previous GWAS or meta-analysis of GWAS based on either East Asian population or Caucasian population. Criteria were as follows: (1) all SNPs were discovered by GWAS, all of which exceeded a genome-wide significance level (*P* \< 5.0 × 10^−8^) in a single ethnicity;

2.  all SNPs were confirmed in independent sets of case-control studies with same direction of effect;

3.  the sample size of the original study is larger than 500 cases vs 500 controls.

Taken together, 17 SNPs from either East Asian population or Caucasian population were identified according to the above criteria, and we were able to genotype eight of them in the current study. Genotyping was performed using the MassARRAY iPLEX (Sequenom, Inc., San Diego, CA) and experiments were carried out according to the manufacturer\'s protocol. Primers were designed using MassARRAY Assay Design 3.1 software (Sequenom, Inc., San Diego, CA). The reactions were performed in 384-well plates. Each plate contained four duplicate subjects selected at random, as well as 4 negative controls in which water was substituted for DNA. The average concordance rate was 100%.

2.3. Statistical analyses
-------------------------

All the SNPs were evaluated for Hardy-Weinberg equilibrium using a goodness-of-fit *χ*^2^ test. The genetic association between SNPs and BCa were analyzed by comparing allelic frequencies of these SNPs between cases and controls. A genetic score was calculated for each individual based on personal genotype of five SNPs (3 SNPs are significantly associated with BCa risk, two SNPs have the same effect with reported GWAS although not significant). The genetic score of each individual was weighted by odd ratios (ORs):

1.  the allelic OR for each SNP was obtained from external studies;

2.  the genotypic OR was calculated assuming a multiplicative model of allelic OR;

3.  the relative risk to average risk level in Chinese population was calculated based on genotypic OR and genotype frequency (HapMap CHB population data);

4.  the final genetic score of each individual was calculated by multiplying relative risk of each SNP.

A student *t*-test was applied in comparing continuous variables and a chi-square test was used in analyzing categorical data. A Cochran-Armitage trend test was used to evaluate the increasing likelihood of BCa with different GRS ranges in the study population. All the statistical analyses above were performed using SPSS 19.0 (Statistical Product and Service Solutions, IBM Corporation, Armonk, NY) and R version 3.4.3 (R Foundation for Statistical Computing, Vienna, Austria). A 2-tailed *P*-value of less than .05 was considered the threshold for statistical significance.

2.4. Ethical approval
---------------------

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board of Huashan Hospital, Fudan University, Shanghai, China (KY2011-009) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written Informed consent was obtained from all individual participants included in the study.

3. Results
==========

Baseline characteristics of 581 BCa cases and 1561 healthy controls were summarized in Table [1](#T1){ref-type="table"}. The average age was similar between BCa patients and healthy controls (64.0 vs 62.7, *P* = .06). Since the healthy physical examination and survey was focusing on males, so 99.9% of subjects in the control cohort were males. Among 581 BCa cases, we were able to acquire the smoking history from 490 subjects. 119 (20.5%) BCa patients had a heavy smoking history (a smoking history ≥ 20 years with daily consumption of ≥ 20 cigarettes), while 355 out of 1561 (22.7%) control subjects had a heavy smoking history (*P* = .29, Table [1](#T1){ref-type="table"}). Over half of the BCa cases were low grade carcinoma or Papillary urothelial neoplasm of low malignant potential (PUNLMP) (52.5%), and 60.3% of the cases were non-muscle invasive BCa (NMIBC).
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Characteristics of study subjects.
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All candidate SNPs passed Hardy-Weinberg equilibrium test in control group. The association of eight SNPs and BCa risk is presented in Table [2](#T2){ref-type="table"} (including both allelic and genotypic results). Among eight SNPs, in terms of allelic tests, rs798766 at 4p16.3 (OR = 1.39, *P* \< .001), rs9642880 (OR = 1.17, *P* \< .001) and rs4813953 at 20p12.2 (OR = 1.09, *P* \< .001) were significantly associated with increased risk of BCa (Table [2](#T2){ref-type="table"}). For genotypic tests, significant associations were found for rs798766 in all 3 genetic models, and for rs4813953 in recessive and additive model, respectively. Meanwhile, 2 other SNPs (rs401681 at 5p15.33 and rs1014971 at 22q13.1) demonstrated the same magnitude of effect for BCa risk, yet not statistically significant (Table [2](#T2){ref-type="table"}). Since rs401681 and rs1014971 were proved to be associated with BCa risk in East Asian in previous study,^\[[@R13]\]^ all these 5 SNPs mentioned above were used to calculate GRS (Table [3](#T3){ref-type="table"}). In addition, false positive report probabilities ^\[[@R14]\]^ were calculated for each SNP to validate the results (Supplementary Table 1). We found that false positive report probabilities values of rs798766 and rs9642880 remained below 0.5 in the estimated prior probability range (0.01--0.25), indicating a strong correlation between these 2 SNPs and BCa risk. Yet a similar but weaker result was found for rs4813953.
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Association analysis results of 8 single nucleotide polymorphisms for bladder cancer in Chinese population.
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Summarization of 5 single nucleotide polymorphisms for calculation of genetic risk scores.
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Overall, the mean GRS was significantly higher in BCa cases than in controls (1.22 vs 1.01, *P* \< .001, Table [1](#T1){ref-type="table"}). To further evaluate the utility of the GRS, all subjects were stratified into 3 groups according to their GRS distribution, and the likelihoods of BCa were revealed in Figure [1](#F1){ref-type="fig"}A. The likelihoods of BCa in subjects with low (\<0.8), medium (0.8--1.2) and high (\>1.2) GRS was 25.2%, 33.7%, 55.0% respectively (*P*-trend \< 2.2 × 10^−16^). The study population was then stratified into 4 groups based on the quartiles of the GRS (Fig. [1](#F1){ref-type="fig"}B). The likelihoods of BCa for individuals with low (0--25% percentile), medium-low (25%-50% percentile), medium-high (50%-75% percentile) and high (75%-100% percentile) GRS would be 19.5%, 35.9%, 40.7% and 60.4% (*P*-trend \< 2.2 × 10^−16^). While evaluating the predictive performance for BCa risk, the area under curve (AUC) of GRS was 0.679 (95% CI: 0.650 - 0.705) (Fig. [2](#F2){ref-type="fig"}).

![Bladder cancer incidence in different genetic risk scores group in the study population. A) The likelihood of BCa in 3 groups with low (\<0.8), medium (0.8--1.2) and high (\>1.2) genetic risk score. B) The likelihood of BCa in four quartiles according to each individual\'s genetic risk score.](medi-99-e19980-g004){#F1}

![ROC curve of the genetic risk score model.](medi-99-e19980-g005){#F2}

In addition, we performed subgroup analyses of GRS in BCa patients with different grades and stages (Table [4](#T4){ref-type="table"}). No significant difference was seen in the mean GRS between patients with low grade BCa (including PUNLMP and low grade disease) and high grade BCa (1.22 vs 1.20, *P* = .71). Similar result was also observed between NMIBC and muscle invasive bladder cancer (MIBC) cases.
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Genetic score in bladder cancer cases with different grades and stages.
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4. Discussion
=============

Genetic risk score has the potential for personal risk predication in several diseases, such as diabetes mellitus,^\[[@R15],[@R16]\]^ coronary heart diseases^\[[@R17],[@R18]\]^ and cancers.^\[[@R19]--[@R21]\]^ In the current study, our objective was to evaluate whether GRS could reflect the inherited risk of BCa. Here we calculated GRS for each individual based on results of association analysis, and we found GRS could reveal the personal risk for BCa in Chinese population.

Hereditary traits have been considered essential in the development of BCa. Case-control study in Italy confirmed a two-fold increased BCa risk for individuals with positive family history of BCa.^\[[@R7]\]^ In a large population-based study, individuals with first- or second-degree relatives diagnosed of BCa had an increased risk of developing urothelial cancer.^\[[@R22]\]^ However, only 2% to 3% of the subjects had a positive family history of BCa,^\[[@R7]\]^ which made it difficult to evaluate inherited risk for the majority of population by family history. Moreover, family history is uninformative in China due to the relatively poor public healthcare and birth control policy during past decades. The prevalence was even lower in the current study, 490 out of 581 BCa cases provided their family history, among which only five patients (1.02%) had a positive family history of BCa (three subjects had first-degree relatives with BCa). Such low prevalence may be caused by the unawareness of disease for family members when providing the family history information. An advantage of GRS over family history is the objective measurement of disease risk, not susceptible to various issues during the collection of family history and other recall bias.

In current study, we performed an external validation of the associations between eight SNPs and BCa in Chinese population. For all validated variants, the minor allele frequencies of all SNPs were over .05, indicating they are not rare variants in Chinese population (Table [2](#T2){ref-type="table"}). Meanwhile, the risk allele frequency in the control group share similar frequencies with previous studies in East Asian.^\[[@R9],[@R10],[@R23],[@R24]\]^ GRS was calculated based on five SNPs (rs798766, rs9642880, rs4813953, rs401681 and rs1014971) which had consistent direction with reported GWAS of BCa (OR \> 1) (Table [3](#T3){ref-type="table"}). GRS was calculated based on these five SNPs which had consistent direction with reported GWAS of BCa (OR \> 1). The SNP rs798766 is associated with BCa risk in both European and East Asian populations.^\[[@R11],[@R25]\]^ It is located in an intron of *TACC3*. Although no direct association of BCa risk between rs798766 and the expression of *TACC3* was observed. A significant association between rs798766 and *FGFR3* expression was observed for BCa risk, so it is biologically plausible that rs798766 may influence *FGFR3* expression by altering distant regulatory elements.^\[[@R11]\]^*FGFR3* somatic mutation is common in NMIBC patients and may predict a good prognosis.^\[[@R26],[@R27]\]^ Rs9642880 has also been identified and verified in both Caucasian and Chinese population.^\[[@R9],[@R23],[@R27]\]^ It is located 30 kb upstream of c-MYC oncogene, which mediates cell growth regulation, differentiation and apoptosis. Rs4813953 was found associated with BCa risk from an Icelandic GWAS and then validated by a multi-ethnic meta-analysis of 17 studies.^\[[@R10]\]^ Two other SNPs (rs1014971 and rs401681) were also correlated with increased BCa risk in Chinese population in previous report.^\[[@R11]\]^ The etiologic mechanism is largely unknown.

It is well recognized that a genetic score based on risk-associated SNPs could be a supplementary tool to family history, and could provide more precise predication for personal cancer risk.^\[[@R19]--[@R21]\]^ GRS is multiplied by all SNPs and each SNP is population-standardized, the mean GRS in the general population is expected to be 1.0.^\[[@R10],[@R12]\]^ In the current study, the mean GRS was 1.01 in the healthy controls, which was expected to be a sample from the general population. In comparison, the mean GRS was 1.22 in BCa cases, which was significantly higher than in the healthy controls. For individuals with high GRS (\> 1.2), the risk of BCa would be 1.6- folds and 2.1- folds higher compared to those who have medium GRS (0.8--1.2) and low GRS (\<0.8). In contrast to subjects with GRS in the lowest quantile, those with GRS in the highest quantile had an OR of 3.10 (Fig. [1](#F1){ref-type="fig"}B). In addition, while evaluating the cancer predictive performance of GRS, it yielded an AUC of 0.679, indicating it could predict the risk of BCa. The AUC was not high, this might be attributed to the nature of GRS was a predictive model rather than a diagnostic test. These results indicated GRS was useful to evaluate inherited risk of developing sporadic BCa. Therefore, GRS may have the potential to inform susceptible population for early regular examination of BCa (eg, urine test, molecular biomarkers, and ultrasound).

There were several limitations of this study. First, the sample size of BCa cases was relatively small, so that several BCa risk-associated SNPs from GWAS in East Asians were not validated with significant results. Studies in larger populations are needed to provide external validation and further evaluation between GRS incorporating more SNPs and BCa. Second, not all BCa risk associated SNPs were included; however, the purpose of this study was to demonstrate the utility of GRS in Chinese population, which was fulfilled. Third, almost all subjects in the control cohort were males, which caused the imbalance of gender distribution between cases and controls. This was due to the previous healthy physical examination and survey process was focusing on males, although such gender distribution imbalance would not influence the genetic study results, it might lead to the higher proportion of heavy smokers in control cohort than in cases (22.7% vs 20.5%, *P* = .29).

5. Conclusions
==============

Among 8 candidate SNPs evaluated in this study, 3 SNPs (rs798766, rs9642880, rs4813953) were significantly associated with increased risk of BCa in Chinese population. GRS based on these SNPs could reveal the inherited risk of BCa.
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